Arysta LifeScience, previously owned by Permira Funds, has been acquired by Platform Specialty Products Corporation, a global diversified specialty chemicals company listed on the New York Stock Exchange. This acquisition marks Platform's third acquisition within the crop protection operating segment after the acquisitions of Agriphar on October 1, 2014 and Chemtura AgroSolutions ("CAS") on November 3, 2014.
Through the Arysta, CAS and Agriphar businesses, Platform now has an operating agrochemicals footprint in more than 100 countries, providing one of the most comprehensive, global line-ups of both traditional and non-traditional crop solutions with sales of over $2.0 billion. The new entity is called Arysta LifeScience and Arysta's President and Chief Executive Officer, Wayne Hewett, took over as Platform's President.
In the new set up, Pakistan will be part of the South Asia Region that also includes businesses in Thailand, Vietnam, Myanmar, Indonesia, Malaysia, Singapore and Philippines. Dr Amir Jafri has been appointed Regional Head-South Asia and will lead Arysta's growth in the region. He was previously looking after Arysta's businesses in Pakistan and Indonesia. Dr Jafri is the current President of Oxford Business Alumni Pakistan and, prior to joining Arysta, worked for ICI, Rhone Poulenc and Bristol Myers Squibb at leadership positions.-PR
Comments
Comments are closed.